Please login to the form below
Diabetes prevention
This page shows the latest Diabetes prevention news and features for those working in and with pharma, biotech and healthcare.
World Diabetes Day 2019
The findings coincide with World Diabetes Day, a global awareness campaign focused on diabetes mellitus. ... Diabetes is a chronic condition, and is a leading cause of blindness, lower-limb amputation, cardiovascular disease and kidney failure.
Latest news
-
Provention Bio wins PRIME designation for type 1 diabetes prevention drug
Back in June, Provention Bio saw its share price double after releasing data which showed that the experimental immunotherapy could delay the onset of type 1 diabetes in children and adults ... prevention of relapse," stated Ashleigh Palmer, CEO of
-
Tiziana joins type 1 diabetes prevention field
It is being evaluated in the treatment of a range of autoimmune diseases, including type 1 diabetes among others. ... Tiziana’s proprietary technology for the oral and nasal delivery of mAb’s in general, and foralumab specifically, have strong
-
Type 1 diabetes prevention promise sends Provention Bio soaring
Jeffrey Bluestone, a distinguished diabetes researcher and a director of Provention Bio had worked on the drug for over 30 years, and was instrumental in in-licensing. ... Teplizumab is the first immune modulator to show a delay in the clinical onset of
-
Amarin hits jackpot with astonishing heart benefits from fish oil product
elevated triglycerides (TGs) between 150-499 mg/dL (median baseline 216 mg/dL) and either established cardiovascular disease (secondary prevention cohort) or diabetes mellitus and at least one other CV risk ... factor (primary prevention cohort).
-
Merck to pilot digital behavioural change programme
The German pharmaceutical company will work with Blue Mesa Health to provide the US digital therapeutics firm’s chronic disease prevention programme to diabetes patients. ... Blue Mesa is in a unique position to deliver culturally tailored diabetes
More from news
Approximately 1 fully matching, plus 29 partially matching documents found.
Latest Intelligence
-
The rising prevalence of diabetes in Europe
Added to this is the unexplained increase of type 1 diabetes in children. ... The network wants to see action on several fronts:. Prevention. Keeping those with diabetes healthy.
-
The Chinese diabetes challenge
Novo Nordisk has also placed great emphasis on physician training in diabetes, focusing on prevention, screening, optimising treatment and patient communication. ... Another leading player in China in the diabetes sector, Bayer, has also placed emphasis
-
Interview: Peter Meeus, Novo Nordisk
Whatever they do to raise awareness of diabetes in terms of prevention, diagnosis and treatment we are also supporting.”. ... This can be a diabetes clinic or a programme to support diabetes footcare for example.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest appointments
-
New hires at bluebird bio, BioNTech and Provention Bio
In his role as CCO at Provention, Hoitt will be responsible for the development and execution of the company’s global commercial strategy for its type 1 diabetes prevention immunotherapy ... one diabetes (T1D) patients and at-risk individuals and, in
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
A new vision for tackling key illnesses
Diabetes. The NHS plans to double the size of the NHS Diabetes Prevention Programme for type 2 diabetes. ... The Long-term Plan shows how technology will help to move diabetes services out of hospitals and support self-care.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Gilead agrees $21bn buyout of Immunomedics
- New medical communications agency BOLDSCIENCE launches
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- Moderna inks R&D agreements with Vertex and Chiesi
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Could formulary intelligence be your brand differentiator?
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Porterhouse Medical strengthens its senior management team
PMHub
Cuttsy + Cuttsy
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...
Latest intelligence
- Could formulary intelligence be your brand differentiator?
- Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
Quick links
Infographics
